685 related articles for article (PubMed ID: 25894638)
1. Phosphate homeostasis and genetic mutations of familial hypophosphatemic rickets.
Razali NN; Hwu TT; Thilakavathy K
J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1009-17. PubMed ID: 25894638
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic role of Fgf23 in Dmp1-null mice.
Liu S; Zhou J; Tang W; Menard R; Feng JQ; Quarles LD
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E254-61. PubMed ID: 18559986
[TBL] [Abstract][Full Text] [Related]
3. Familial hypophosphatemic rickets caused by a large deletion in PHEX gene.
Saito T; Nishii Y; Yasuda T; Ito N; Suzuki H; Igarashi T; Fukumoto S; Fujita T
Eur J Endocrinol; 2009 Oct; 161(4):647-51. PubMed ID: 19581284
[TBL] [Abstract][Full Text] [Related]
4. A Mutation in the Dmp1 Gene Alters Phosphate Responsiveness in Mice.
Ichikawa S; Gerard-O'Riley RL; Acton D; McQueen AK; Strobel IE; Witcher PC; Feng JQ; Econs MJ
Endocrinology; 2017 Mar; 158(3):470-476. PubMed ID: 28005411
[TBL] [Abstract][Full Text] [Related]
5. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.
Quarles LD
Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E1-9. PubMed ID: 12791601
[TBL] [Abstract][Full Text] [Related]
6. A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells.
Ichikawa S; Austin AM; Gray AK; Econs MJ
J Bone Miner Res; 2012 Feb; 27(2):453-60. PubMed ID: 22006791
[TBL] [Abstract][Full Text] [Related]
7. PHEX 3'-UTR c.*231A>G near the polyadenylation signal is a relatively common, mild, American mutation that masquerades as sporadic or X-linked recessive hypophosphatemic rickets.
Mumm S; Huskey M; Cajic A; Wollberg V; Zhang F; Madson KL; Wenkert D; McAlister WH; Gottesman GS; Whyte MP
J Bone Miner Res; 2015 Jan; 30(1):137-43. PubMed ID: 25042154
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular heterogeneity in a large series of patients with hypophosphatemic rickets.
Capelli S; Donghi V; Maruca K; Vezzoli G; Corbetta S; Brandi ML; Mora S; Weber G
Bone; 2015 Oct; 79():143-9. PubMed ID: 26051471
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of patients with FGF23-related hypophosphatemic rickets.
Kinoshita Y; Saito T; Shimizu Y; Hori M; Taguchi M; Igarashi T; Fukumoto S; Fujita T
Eur J Endocrinol; 2012 Aug; 167(2):165-72. PubMed ID: 22577109
[TBL] [Abstract][Full Text] [Related]
10. FGF23 and syndromes of abnormal renal phosphate handling.
Bergwitz C; Jüppner H
Adv Exp Med Biol; 2012; 728():41-64. PubMed ID: 22396161
[TBL] [Abstract][Full Text] [Related]
11. Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia.
Feng JQ; Clinkenbeard EL; Yuan B; White KE; Drezner MK
Bone; 2013 Jun; 54(2):213-21. PubMed ID: 23403405
[TBL] [Abstract][Full Text] [Related]
12. Osteocytes and the pathogenesis of hypophosphatemic rickets.
Yamazaki M; Michigami T
Front Endocrinol (Lausanne); 2022; 13():1005189. PubMed ID: 36246908
[TBL] [Abstract][Full Text] [Related]
13. A patient with hypophosphatemic rickets and ossification of posterior longitudinal ligament caused by a novel homozygous mutation in ENPP1 gene.
Saito T; Shimizu Y; Hori M; Taguchi M; Igarashi T; Fukumoto S; Fujitab T
Bone; 2011 Oct; 49(4):913-6. PubMed ID: 21745613
[TBL] [Abstract][Full Text] [Related]
14. Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway.
Rowe PS
Crit Rev Eukaryot Gene Expr; 2012; 22(1):61-86. PubMed ID: 22339660
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of PHEX, FGF23 and DMP1 in a cohort of patients with hypophosphatemic rickets.
Ruppe MD; Brosnan PG; Au KS; Tran PX; Dominguez BW; Northrup H
Clin Endocrinol (Oxf); 2011 Mar; 74(3):312-8. PubMed ID: 21050253
[TBL] [Abstract][Full Text] [Related]
16. Inherited hypophosphatemic disorders in children and the evolving mechanisms of phosphate regulation.
Bastepe M; Jüppner H
Rev Endocr Metab Disord; 2008 Jun; 9(2):171-80. PubMed ID: 18365315
[TBL] [Abstract][Full Text] [Related]
17. Dosage effect of a Phex mutation in a murine model of X-linked hypophosphatemia.
Ichikawa S; Gray AK; Bikorimana E; Econs MJ
Calcif Tissue Int; 2013 Aug; 93(2):155-62. PubMed ID: 23700148
[TBL] [Abstract][Full Text] [Related]
18. X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.
Kinoshita Y; Fukumoto S
Endocr Rev; 2018 Jun; 39(3):274-291. PubMed ID: 29381780
[TBL] [Abstract][Full Text] [Related]
19. Impaired Growth Plate Maturation in XLH Is due to Both Excess FGF23 and Decreased 1,25-Dihydroxyvitamin D Signaling.
Yadav PS; Kobelski MM; Martins JS; Tao T; Liu ES; Demay MB
Endocrinology; 2023 Nov; 165(1):. PubMed ID: 38066669
[TBL] [Abstract][Full Text] [Related]
20. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.
Liu S; Gupta A; Quarles LD
Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):329-35. PubMed ID: 17565275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
